第三代TKIs 在EGFR 突变非小细胞肺癌中的应用

许雯雯, 朱宇熹 - 肿瘤防治研究, 2021 - zlfzyj.com
… about third-generation TKIs on NSCLC adverse eventsEfficacy and safety of osimertinib in
treating EGFR-mutated … prior therapy on the efficacy of osimertinib in patients with non-small …

黄芪多糖对非小细胞肺癌患者外周血CA125, VEGF 及MMP-9 表达的影响.

雷琰, 白军林, 于晓宁, 张巍… - Progress in Modern …, 2015 - search.ebscohost.com
… , the clinical efficacy, blood routine and CA125, VEGF and MMP-9 expression levels in
peripheral blood were compared between two groups. ① After treatment, the clinical efficacy of …

[HTML][HTML] 非小细胞肺癌脑转移患者的靶向治疗进展

杨柳, 韦利群, 刘羽, 张俊红, 谢丛华, 周云峰 - 武汉大学学报(医学版), 2018 - xml-data.org
… are effective options with acceptable side effects. We will review the efficacy of different
targeted drugs or … Gefitinib with whole brain radiotherapy for patients with brain metastasis …

胸腔镜肺楔形切除术与胸腔镜肺叶切除加纵隔淋巴结清扫术治疗早期非小细胞肺癌患者的临床效果比较.

魏周斌, 赵亮, 张俣, 马越 - Progress in Modern …, 2020 - search.ebscohost.com
… To compare the clinical effects of thoracoscopic pulmonary … Afatinib versus gefitinib in patients
with EGFR mutation-… lung cancer receiving first-line gefitinib or erlotinib treatment[J]. Asia - …

[HTML][HTML] 抗血管生成药物联合EGFR-TKI 治疗EGFR 突变晚期非小细胞肺癌的研究进展

李博文, 薛剑超, 王亚东, 黄志诚, 梁乃新… - Chinese Journal of …, 2022 - ncbi.nlm.nih.gov
… However, compared to EGFR-TKI monotherapy, the benefits of the A+T treatment based on
… 联合用药也会导致不良事件(adverse events, AEs)的增加,但这种增加似乎是两种药物AEs的…

[PDF][PDF] 厄洛替尼治疗非小细胞肺癌并发贫血的Meta 分析

马虎, 周建国, 柏玉举, 张钰, 王菲, 王怡… - 中华肿瘤防治 …, 2016 - researchgate.net
… the anemia of erlotinib plus chemotherapy(CT)or erlotinib alone for … anemia of erlotinib plus
chemotherapy or alone compared with conventional … Comparison of the efficacy and safety of …

[HTML][HTML] 老年晚期非小细胞肺癌姑息治疗获益研究进展

蒋姗彤, 李萍萍 - Chinese Journal of Lung Cancer, 2015 - ncbi.nlm.nih.gov
… It also has the highest incidence when compared to other … (EGFR) mutation can benefit
from gefitinib and have a good … Efficacy of xiao-ai-ping injection treatment of elderly patients

[PDF][PDF] 奥希替尼治疗晚期肺腺癌1 例并文献复习

刘源, 倪渐凤, 刘丽娜, 尹先哲 - 临床与病理杂志, 2020 - cdn.amegroups.cn
… the clinical efficacy and adverse reactions of a patient with … inhibitors (EGFR-TKIs) (gefitinib)
for treatment with osimertinib, and … Figure 8 Comparison of CT image of lung between April …

[HTML][HTML] 晚期肺腺癌患者维持治疗中EGFR-TKI 联合贝伐珠单抗的回顾性分析

胡雪婷, 王康, 罗虎, 周向东 - 2021 - aammt.tmmu.edu.cn
… [Abstract] Objective To compare the efficacy and safety of … Methods Clinical data of 192
patients with advanced lung … The rate of grade 3 or worse adverse events were 14% versus 7% in …

非小细胞肺癌分子靶向治疗研究进展

张琨, 寿伟臻 - Advances in Clinical Medicine, 2016 - hanspub.org
effect for patients with early lung cancer and patients with good physique, the rising space
of the treatment effect … Lung cancer molecular target-ing therapy, compared with traditional …